by Five Rivers Rx | May 20, 2020 | DEA, Industry News, Suspicious Order Monitoring
Omnicare, a leading provider of closed-door pharmacy services, agreed to pay more than a $15 million civil penalty for allowing opioids and other controlled substances to be dispensed without a valid prescription. The fine zeroes in on a common issue amongst...
by Five Rivers Rx | Mar 12, 2020 | DEA, Suspicious Order Monitoring
The settlement between the California Board of Pharmacy and AmerisourceBergen demonstrates the importance of embracing Suspicious Order Monitoring as a systematic and procedural Background The California Board of Pharmacy settled its longstanding investigation of...
